PP
PTLA

PDT Partners’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

PDT Partners’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-118,531
Closed -$2.83M – 922
2019
Q4 		$2.83M Buy
+118,531
New +$3.27M 0.17% 161
2015
Q2 		– Sell
-50,749
Closed -$1.93M – 1756
2015
Q1 		$1.93M Buy
+50,749
New +$1.74M 0.05% 471
2013
Q4 		– Sell
-7,478
Closed -$200K – 1302
2013
Q3 		$200K Buy
+7,478
New +$178K 0.01% 1396

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

PDT Partners's PTLA Position: Q1 2020 in Review

PDT Partners sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2020, closing a stake of 118,531 shares — an estimated $2.83M sold.

PDT Partners first reported a position in PTLA in Q3 2013 and held it in 3 quarters. The position peaked at $2.83M in Q4 2019. 187 funds tracked by Wall St. Rank hold PTLA as of Q1 2020.

  • PDT Partners reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
  • PDT Partners sold 118,531 Portola Pharmaceuticals, Inc. shares in Q1 2020, an estimated $2.83M.
  • PDT Partners first reported a position in Portola Pharmaceuticals, Inc. in Q3 2013 and held it in 3 quarters.
  • PDT Partners's Portola Pharmaceuticals, Inc. position peaked at $2.83M in Q4 2019.
  • 187 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2020.

Based on PDT Partners's 13F filing for Q1 2020, filed 15 May 2020.